BAUMER (BALM3) Main Indicators
Basic Data - BALM3
| Company | BAUMER |
| Corporate Name | BAUMER S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Tradicional - BOVESPA |
| Activity | Fabricação aparelhos e instrumentos p/ uso medico hospitalar e ortopedia |
| Share | BALM3 |
| Quote Date | 09/17/2024 |
| Share Type | ON |
| Last Closing | R$ 13.00 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 1.30 thousand |
| Last Statement | ITR - 06/30/2024 |
| Sector | Saúde |
| Subsector | Equipamentos |
| Segment | Equipamentos |
| Participation Indexes | - |
| Updated 09/19/2024 | |
Relative Prices - BALM3
| Price/Earnings | 9.27 |
| Price/SBV | 0.81 |
| Price/Net Sales | 0.77 |
| Price/CFO | 5.41 |
| Price/FCF | 7.44 |
| Price/Total Assets | 0.48 |
| Price/EBIT | 6.92 |
| Price/Working Capital | 1.06 |
| Price/NCAV | 8.99 |
| EV/EBIT | 6.59 |
| EV/EBITDA | 5.18 |
| EV/Net Sales | 0.73 |
| EV/CFO | 5.15 |
| EV/FCF | 7.09 |
| EV/Total Assets | 0.46 |
| Company Market Cap | R$ 115.64 M |
| Enterprise Value | R$ 121.30 M |
| Current Financial Statement Date | 06/30/2024 |
| Current Share Price | R$ 13.00 |
| Share Price Date | 09/17/2024 |
| Dividend Yield | 5.97% |
| Updated 09/19/2024 | |
Income Statement - BALM3
| Net Revenue | R$ 166.03 M |
| Gross Result | R$ 102.81 M |
| EBIT | R$ 18.41 M |
| Depreciation and Amortization | - R$ 5.00 M |
| EBITDA | R$ 23.41 M |
| Net Profit | R$ 13.74 M |
| Net Profit/Share | R$ 1.40 |
| Updated 08/14/2024 | |
| Net Revenue | R$ 46.03 M |
| Gross Result | R$ 26.96 M |
| EBIT | R$ 4.81 M |
| Depreciation and Amortization | - R$ 1.28 M |
| EBITDA | R$ 6.09 M |
| Net Profit | R$ 7.69 M |
| Profit/Share | R$ 0.78 |
| Updated 08/14/2024 | |
Price and Volume Behavior - BALM3
| Lowest Price 52 weeks | R$ 9.11 |
| Highest Price 52 weeks | R$ 13.00 |
| Variation 2024 | 24.88% |
| Variation 1 year | 35.77% |
| Variation 2 years(total) | 14.90% |
| Variation 2 years(yearly) | 7.14% |
| Variation 3 years(total) | -17.57% |
| Variation 3 years(yearly) | -6.23% |
| Variation 4 years(total) | -15.85% |
| Variation 4 years(yearly) | -4.22% |
| Variation 5 years(total) | 24.37% |
| Variation 5 years(yearly) | 4.37% |
| Average Daily Volume (3 months) | R$ 301.51 |
| Updated 09/19/2024 | |
Returns and Margins - BALM3
| Return on Initial Tangible Capital | 6.83% |
| Return on Initial Invested Capital | 7.97% |
| Pre-Tax Return on Initial Tangible Capital | 10.35% |
| Pre-Tax Return on Initial Invested Capital | 12.08% |
| Return on Initial Shareholder´s Equity | 9.65% |
| Return on Initial Asset | 5.54% |
| Gross Margin | 61.93% |
| Net Margin | 8.28% |
| EBIT Margin | 11.09% |
| EBITDA Margin | 14.10% |
| Initial Asset Turnover | 0.67 |
| Financial Leverage | 1.67 |
| Liabilities/Net Worth | 0.67 |
| Net Debt/EBITDA | 0.24 |
| Updated 08/14/2024 | |
Balance Sheet - BALM3
| Cash and Cash Equivalents | R$ 12.63 M |
| Total Assets | R$ 263.44 M |
| Short-Term Debt | R$ 2.01 M |
| Long-Term Debt | R$ 16.28 M |
| Gross Debt | R$ 18.29 M |
| Net Debt | R$ 5.66 M |
| Shareholder´s Equity | R$ 157.92 M |
| Share Book Value | R$ 16.11 |
| Common Shares | 4,900,000 |
| Preferred Shares | 4,900,000 |
| Total | 9,800,000 |
| Common Shares in Treasury | 11,890 |
| Preferred Shares in Treasury | 3,600 |
| Total in Treasury | 15,490 |
| Common Shares (Except Treasury) | 4,888,110 |
| Preferred Shares (Except Treasury) | 4,896,400 |
| Total (Except Treasury) | 9,784,510 |
| Updated 08/14/2024 | |
Cash Flow - BALM3
| Operating Cash Flow | R$ 23.57 M |
| Cash Flow from Investments | - R$ 3.84 M |
| Financing Cash Flow | - R$ 6.02 M |
| Increase (Reduction) in Cash and Equivalents | R$ 13.70 M |
| Updated 08/14/2024 | |
| Operating Cash Flow | R$ 8.61 M |
| Cash Flow from Investments | - R$ 841.00 thousand |
| Financing Cash Flow | - R$ 3.74 M |
| Increase (Reduction) in Cash and Equivalents | R$ 4.03 M |
| Updated 08/14/2024 | |
Experimental - BALM3
| CAPEX 3 months | - R$ 1.60 M |
| Free Cash Flow 3 months | R$ 7.02 M |
| CAPEX 12 months | - R$ 6.45 M |
| Free Cash Flow 12 months | R$ 17.11 M |
| Updated 08/14/2024 | |